WVE Q2 2018 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+621.7% YoY

Gross Profit

-$28M-567.1% margin

Operating Income

-$37M-749.6% margin

Net Income

-$36M-735.7% margin

EPS (Diluted)

$-1.23

QoQ Revenue Growth

+243.1%

Cash Flow

Operating Cash Flow

$71M

Free Cash Flow

$69M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$354M

Total Liabilities

$214M

Stockholders' Equity

$139M

Cash & Equivalents

$241M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$676,000	+621.7%
Gross Profit	-$28M	-$18M	-50.1%
Operating Income	-$37M	-$25M	-45.7%
Net Income	-$36M	-$25M	-45.4%